Low-molecular-weight bovine collagen peptides reduced visceral fat by up to 28%, improved glucose tolerance by 26%, and increased gut microbiome diversity in diet-induced obese mice.
26% improvement in glucose toleranceThe only statistically significant metabolic outcome (p<0.05) in obese mice after 8 weeks of collagen peptide supplementation
What the researchers found
In C. elegans, low-molecular-weight bovine collagen hydrolysate (2 mg/mL) significantly reduced fat accumulation and reactive oxygen species, slowed aging (measured by lipofuscin), and extended median lifespan.
In 32 male diet-induced obese C57BL/6 mice, 8 weeks of daily supplementation (1 mg/animal/day) produced significant reductions in adipose tissue: mesenteric fat decreased 28%, visceral fat decreased 15%, and total adipose tissue decreased 18%. Glucose tolerance improved markedly, with a 26% reduction in area under the curve on glucose tolerance testing (p < 0.05). The collagen peptides also significantly increased gut microbiota diversity and shifted bacterial populations toward beneficial species.
Why it matters
Collagen peptide supplements are already widely consumed for skin and joint health, making them accessible and generally well-tolerated. If they also provide meaningful metabolic benefits — reducing visceral fat, improving blood sugar control, and supporting gut health — it would add significant value to an already popular supplement category. The gut microbiome changes are particularly interesting because they suggest a mechanism by which collagen peptides might influence metabolism systemically.
The numbers in context
Mesenteric fat ↓28%, visceral fat ↓15%, total fat ↓18% (p>0.05); glucose tolerance ↑26% AUC (p<0.05); 32 mice; 8 weeks; 1 mg/day; C. elegans: 2 mg/mL
How the study worked
Researchers tested low-molecular-weight bovine collagen hydrolysate (COLLinstant® LMW) in two model organisms. In C. elegans worms, they measured fat accumulation (Nile Red staining), reactive oxygen species (dihydroethidium), aging markers (lipofuscin), and lifespan. In 32 male diet-induced obese C57BL/6 mice, they supplemented daily for 8 weeks and measured adipose tissue depots, glucose tolerance (intraperitoneal glucose tolerance test), and gut microbiota composition and diversity.
Who was studied
C. elegans nematodes and 32 male C57BL/6 diet-induced obese mice (20 weeks old)
What this study cannot tell us
The fat tissue reductions (28%, 15%, 18%) were noted to have p > 0.05, meaning they did not reach statistical significance — only the glucose tolerance improvement was significant (p < 0.05). The mouse dose (1 mg/day) may not translate proportionally to a human dose. The study used a specific commercial product (COLLinstant® LMW), so results may not apply to all collagen supplements. Only male mice were studied. The 8-week duration is relatively short. The C. elegans model, while useful for screening, has limited relevance to human metabolism.
How to read the evidence
Rated preliminary because this is an animal study with a relatively small sample size (32 mice). While the glucose tolerance result was statistically significant, the fat reduction outcomes did not reach significance. The C. elegans data provides supportive but not clinically translatable evidence. No human data exists for this specific product's metabolic effects.
When this study was published
Published in 2025, this is very recent research reflecting growing interest in collagen peptides' metabolic effects beyond their traditional use for skin, joints, and bones. The microbiome component is particularly timely given the current scientific focus on gut health.
The bigger picture
This study adds to a growing body of research suggesting collagen peptides have biological effects well beyond structural support. Previous studies have shown collagen peptides can influence satiety hormones, modulate inflammation, and affect fat cell metabolism. The microbiome connection is relatively novel and could explain how an orally consumed protein fragment produces systemic metabolic effects. If these findings translate to humans, collagen peptides could be repositioned as a functional food ingredient for metabolic health, not just cosmetic supplementation.
Questions still open
- Would these metabolic benefits hold up in human clinical trials, and at what dose?
- Which specific gut bacteria were affected by collagen peptide supplementation, and do they directly mediate the metabolic improvements?
- Do the fat reduction effects require longer treatment periods to reach statistical significance, or are they genuinely modest effects?
Common questions
Could taking collagen supplements help with weight loss?
How might collagen peptides affect gut bacteria?
Read the original research
Low-Molecular-Weight Bovine Collagen Peptides Reduce Fat Accumulation in C. elegans and Ameliorate Obesity-Related Metabolic Dysfunction and Microbiota Diversity in C57BL/6 Male Diet-Induced Obese Mice.
International journal of molecular sciences, 26(18)
Citation
López-Yoldi, Miguel; Aranaz, Paula; Riezu-Boj, José I; González-Salazar, Itxaso; Izco, Jesús M; Recalde, José I; González-Navarro, Carlos J; Milagro, Fermín I. (2025). Low-Molecular-Weight Bovine Collagen Peptides Reduce Fat Accumulation in C. elegans and Ameliorate Obesity-Related Metabolic Dysfunction and Microbiota Diversity in C57BL/6 Male Diet-Induced Obese Mice.. International journal of molecular sciences, 26(18). https://doi.org/10.3390/ijms26189149